MDALF(MDALF)
MDALF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.89B | $2.11B | $2.32B |
| Low | $1.86B | $2.08B | $2.29B |
| High | $1.90B | $2.16B | $2.36B |
| EBITDA Avg | $394M | $440M | $485M |
| Low | $389M | $433M | $478M |
| High | $398M | $452M | $494M |
| EBIT Avg | $185M | $207M | $228M |
| Low | $183M | $204M | $224M |
| High | $187M | $212M | $232M |
| Net Income Avg | $203M | $232M | $257M |
| Low | $199M | $227M | $252M |
| High | $208M | $237M | $263M |
| EPS Avg | $1.57 | $1.79 | $1.98 |
| Low | $1.54 | $1.75 | $1.94 |
| High | $1.60 | $1.83 | $2.02 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $466M | $528M | $481M | $505M | $519M | $585M | $515M | $532M |
| Low | $466M | $528M | $481M | $505M | $519M | $585M | $515M | $532M |
| High | $466M | $528M | $481M | $505M | $519M | $585M | $515M | $532M |
| EBITDA Avg | $97M | $110M | $100M | $105M | $108M | $122M | $108M | $111M |
| Low | $97M | $110M | $100M | $105M | $108M | $122M | $108M | $111M |
| High | $97M | $110M | $100M | $105M | $108M | $122M | $108M | $111M |
| EBIT Avg | $46M | $52M | $47M | $50M | $51M | $57M | $51M | $52M |
| Low | $46M | $52M | $47M | $50M | $51M | $57M | $51M | $52M |
| High | $46M | $52M | $47M | $50M | $51M | $57M | $51M | $52M |
| Net Income Avg | $48M | $56M | $48M | $51M | $54M | $62M | — | — |
| Low | $48M | $56M | $48M | $51M | $54M | $62M | — | — |
| High | $48M | $56M | $48M | $51M | $54M | $62M | — | — |
| EPS Avg | $0.38 | $0.44 | $0.38 | $0.41 | $0.43 | $0.49 | — | — |
| Low | $0.38 | $0.44 | $0.38 | $0.41 | $0.43 | $0.49 | — | — |
| High | $0.38 | $0.44 | $0.38 | $0.41 | $0.43 | $0.49 | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / — | 1 / — |